Part-Time
Compensation Partner
Multiple Teams
Posted on 9/17/2025
ZOLL Medical Corporation
1,001-5,000 employees
Cardiac resuscitation devices with integrated software
Compensation Overview
$100k - $130k/yr
Providence, RI, USA + 4 more
More locations: Lowell, MA, USA | Minneapolis, MN, USA | Broomfield, CO, USA | Central Falls, RI, USA
In Person
 Consulting (1) |
|---|
- Bachelor's Degree in business, human resources, or a related field required
- At least five years of compensation or human resources experience
- Strong understanding of broad-based compensation programs (base/bonus/LTI), pay for performance, benchmarking/market data, job evaluation, etc.
- Solid understanding of FLSA classification and the ability to make determinations
- Advanced knowledge of Microsoft Excel, and a deep interest in analyzing data to drive sound decision-making; Workday experience a plus
- Proven organizational skills with attention to detail and the ability to prioritize and work well in an environment with competing demands
- Ability to build relationships of trust and interpersonal skills to interact favorably with all levels of business contacts
- Assist designing and building an innovative, competitive, and analytically driven global compensation structure and administer the company’s global compensation programs in compliance with company policies and government regulations.
- Benchmark jobs against survey data and other market intelligence to determine competitive compensation ranges for each position.
- Gather data from market-based compensation surveys; uses spreadsheet and data analysis techniques to assess results and market trends.
- Evaluate and implement job analysis instruments and materials.
- Partner with the Legal team to evaluate new and existing roles for compliance with the Fair Labor Standards Act (FLSA).
- Oversee participation in and use of salary surveys to ensure corporate compensation programs are competitive. Use salary survey data and comp expertise to recommend appropriate comp positioning for key roles.
- Perform market analysis and provide insight for new and existing roles.
- Audit job descriptions for content such as job responsibilities, activities, duties, and requirements and ensure that they have been appropriately assigned to the correct job family and level within the organization.
- Implement analytics for new or existing compensation programs and execute job evaluations and workforce classification projects.
- Plan and manage compensation, program administration, and automation projects for the compensation team.
- Respond to compensation-related questions from managers, HR business partners and recruiters.
- Perform ad hoc analysis and planning to continuously improve our compensation programs and processes.
- Prepare training content and assist in the delivery of training for HR, business leaders and employees, as appropriate.
- Comply with all policies and standards.
- Any other job responsibilities as assigned by management and subject to modification.
- Workday experience a plus
ZOLL Medical Corporation designs and sells medical devices and software for emergency and critical care. Its products include defibrillators and AEDs, mobile ECG systems, disposable electrodes, temperature management devices, sleep apnea solutions, and software that integrates with hardware to manage patient data. It differentiates itself by offering an integrated hardware-software ecosystem focused on cardiac resuscitation and critical care with a global reach to hospitals and EMS. Its goal is to improve patient outcomes and clinical and operational efficiency through end-to-end, data-enabled emergency and critical care solutions.
Company Size
1,001-5,000
Company Stage
Acquired
Total Funding
$2.2B
Headquarters
Chelmsford, Massachusetts
Founded
1980
Simplify's Take
What believers are saying
- Eric Knudsen's CEO appointment drives growth from 30 years medtech expertise.
- ZOLL Itamar achieves profitability surge under Knudsen's prior leadership.
- EU MDR approval expands Zenix sales in Europe for hospitals and EMS.
What critics are saying
- Medtronic LifePak captures 45% US EMS share, eroding X Series sales.
- Stryker LUCAS 4 beats AutoPulse NXT by 18% ROSC in 2025 AHA trials.
- ResMed NightOwl halves ZOLL Itamar's $200M sleep diagnostics revenue.
What makes ZOLL Medical Corporation unique
- Zenix defibrillator offers Real CPR Help and touchscreen customization for EMS.
- TherOx SSO2 Therapy gains Vizient contract for post-heart attack oxygen delivery.
- AutoPulse NXT deployed nationwide by Air Methods for air medical transports.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Casual Work Environment
Company News
ZOLL, an Asahi Kasei company manufacturing medical devices, has announced that its Zenix monitor/defibrillator received approval under the European Union Medical Device Regulation 2017/745. The device is designed for use in both emergency medical services and hospital settings. Zenix features a large touchscreen and on-the-fly customisation capabilities, allowing healthcare professionals to make real-time adjustments during critical situations. The device incorporates ZOLL's Real BVM Help and Real CPR Help technology, providing clinical feedback to improve ventilation quality and CPR delivery. According to Elijah White, president of ZOLL Acute Care Technology, virtually all device functions are accessible with three screen-touches or fewer. Zenix joins ZOLL's existing portfolio of professional monitors and defibrillators, including the X Series, R Series and M2 models.
ZOLL medical appoints Eric Knudsen as new CEO. CHELMSFORD, Mass. - (BUSINESS WIRE) - ZOLL(R), an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that it has appointed Eric Knudsen as its new Chief Executive Officer, effective April 1. Knudsen will succeed Jon Rennert, who served as ZOLL's CEO for the past 10 years and will assume a new role as Executive Chairman of ZOLL's Board of Directors. "As a global leader in medical technology, ZOLL is continually looking for ways to expand our business and reach more patients in need," said Rennert. "Eric has played a unique role in developing our growth strategies and driving our expansion, and I am confident he will lead ZOLL to even greater growth and success." "I am honored to become ZOLL's next CEO," said Knudsen. "ZOLL has a long legacy of innovation and clinical excellence, and today our medical devices, software, and related services are used worldwide to diagnose and treat patients suffering from serious cardiopulmonary and respiratory conditions. We will continue to lead with our commitment to patients and customers and our passion for improving outcomes and helping save lives." Knudsen has nearly 30 years of experience in the medtech industry, with deep expertise in business development and corporate strategy. He led ZOLL's Corporate Development team for six years and was responsible for investing in strategic relationships and acquiring more than a dozen new technologies. For the past four years, Knudsen was President of ZOLL Itamar, a division of ZOLL that is focused on the diagnosis of sleep disorders. Knudsen led the division through significant growth and a dramatic increase in profitability. Prior to joining ZOLL in 2013, Knudsen held leadership positions in international sales, marketing, and manufacturing partnerships at Covidien (now Medtronic), Aspect Medical Systems, and LeMaitre Vascular. He has an MBA from the Thunderbird School of Global Management and a bachelor's degree from Boston College. Rennert was named CEO of ZOLL in 2016, after serving as President of the company's largest business unit for eight years. Under Rennert's leadership as CEO, ZOLL expanded its reach as a global leader in external defibrillation, pioneered novel solutions for patients with serious cardiopulmonary and respiratory conditions, and significantly broadened its portfolio of products. About ZOLL ZOLL, an Asahi Kasei company, develops and markets medical devices and software solutions that help advance care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and cardiac monitoring, circulation enhancement and CPR feedback, supersaturated oxygen therapy, data management, ventilation, therapeutic temperature management, and sleep apnea diagnosis and treatment, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, as well as lay rescuers, improve patient outcomes in critical cardiopulmonary conditions. For more information, visit www.zoll.com. About Asahi Kasei The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With 50,000 employees worldwide, the company contributes to a sustainable society by providing solutions to the world's challenges through its three business sectors of Healthcare, Homes, and Material. Its healthcare operations include devices and systems for critical care, products and services for the manufacture of biotherapeutics, and a growing portfolio of specialty pharmaceuticals. For more information, visit www.asahi-kasei.com. Asahi Kasei is also dedicated to sustainability initiatives and is contributing to reaching a carbon neutral society by 2050. To learn more, visit https://www.asahi-kasei.com/sustainability/. Matt Hogan ZOLL 978-805-6561 [email protected]
Air Methods collaborated closely with ZOLL to provide direct feedback during the development of the AutoPulse NXT, which was released in 2024.
The ZOLL AR Boost(R) Insurance Discovery tool secured the #1 spot in the 2024 Insurance Discovery Solutions category.
Zoll Medical Corp. is asking a Boston federal judge to toss a proposed class action brought by medical device customers whose personal information was released during a ransomware attack last year...